This Stock Is Up 74% This Year: Is It Too Late to Buy?
The biotech is clearly innovative, but sometimes that’s not enough.
Mindfully Curated
The biotech is clearly innovative, but sometimes that’s not enough.
Adobe and The Trade Desk are selling for relatively attractive valuations.
Investing for the long-term requires a different strategy.
It announced that it’s effectively retiring $100 million in debt.
Micron and Sandisk have pulled back significantly after reaching 52-week highs last month.
An analyst pulled the lever on a rare double upgrade of the oil company.
Will the S&P 500’s gains continue?
First, Palo Alto stock got a price target hike — then it’s stock dropped.
AI agents need a massive amount of memory.
The market is giving investors a gift by putting these two stocks on sale.
The healthcare industry is growing, but UnitedHealth Group may not be the best healthcare investment around.
The AI tailwind isn’t over yet.
Many developments for the company were positive.
Although the stock sold off after the company reported earnings, it staged a quick recovery.
Don’t let it happen to you.
In this episode of The Brainstorm, Brett and Sam are joined by Daniel Maguire to discuss Tesla’s Model Y L and what it could mean for family buyers and robotaxi strategy, plus Rocket Lab’s acquisition of Iridium and the growing importance of satellite …
The incredible demand for advanced chips could help ASML deliver better-than-expected quarterly numbers and guidance.
The fast-growing company could reward investors in a big way.
Investors have an opportunity to buy the dip in a top nuclear industry stock.
Ark Invest added to three existing positions that declined as much as 10% on Tuesday.